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Lifelong learning process is recommended for all 
health care providers, while emphasis is always on the 
routine procedures or the most frequently used parts of 
knowledge (1). As anesthesiologists encounter drug 
administration more than any other specialty in 
medicine, this field seems to be partly neglected in 
continuing medical education.  
Personalized medicine is introduced in recent 
decades in the need of tailoring therapeutic measures 
to ensure optimizing patient care. Pharmacogenetics 
play an essential concept in precision medicine, 
involving both diagnostic and therapeutic fields. 
These new notions are readily accepted as engaging 
research topics in anesthesia, and added to textbooks 
as well; mostly as complementary data or ideas for 
further studies. However, anesthesia is one of the 
specialties facing the different responses to the 
medications on a daily basis, and some of the 
infamous historical aspects of personalized medicine 
started from this discipline. Some notable examples 
rising the concept of gene polymorphism are 
malignant hyperthermia following exposure to 
halogenated anesthetics and/or succinylcholine, or, 
prolonged apnea following succinylcholine 
administration, or porphyria exacerbation after 
anesthesia induction using sodium thiopental. 
Ruano and colleagues introduced one of the 
most practical approaches related to opioid 
administration in anesthesia based on pharmacogenetic 
differences in two of the well-known receptors in 
humans linked to opioid efficacy and toxicity (2). They 
described groups of people with distinct function of 
proteins involved in opioid pharmacokinetics 
(cytochrome P450 2D6) and dynamics (cytochrome 
P450 2D6) and detailed probable reaction of each 
group of patients to perioperative opioids. The authors 
recommended a guideline on how to predict the 
response of each patient to this class of medications 
based on their genetic composition and the prevalence 
of insufficient analgesia or the development of 
dependence. Interestingly, 48% of normal population 
are predicted to be in the category of patients with 
subnormal OPRM1 or CYP2D6, which are explained 
to be in need for dose adjustment or different opioid 
selection! The number is impressive and warns us 
about our daily routines: are we putting our patients in 
danger of dependence while some other are 
challenging inadequate pain management and 
discomfort?  
The above study is one of many, which indicate 
novel surveillance on the topics selected for continuing 
medical education and/or must be recommended to 
working anesthesiologists who may not be familiar to 
these progressive concepts.  
A number of other so-called clinical studies 
have been presented in this issue of JCMA in which 
some other aspects of differences in subcellular 
anesthesia has been noted as well; including the study 
by Nashibi and colleagues, which looks at choosing 
anesthetic agents from "personalized medicine" view. 
In fact, even simple decisions such as the choice of 
maintenance anesthetics could affect our patients 
substantially. Selecting isoflurane or propofol seems to 
have unalike influence on antioxidants, offering further 
options based on patient’s underlying situation or 
surgical trauma and the extent of stress response (3). 
Alternatively, the study by Khalili and colleagues 
suggesting personalized biomarkers of therapeutic 
monitoring for personalized therapies. In addition, 
their study quotes that some adjuvant medications may 
as well serve to improve some of the patients’ state of 
inflammation or decreasing the inflammatory 
responses resulted from the surgery itself, although, it 
should be considered wisely that such effects are 
prominent in just a specific population or in particular 
situations (4). 
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On the other hand, Beheshti Monfared and 
colleagues have discussed a patient with psoriasis 
undergoing CABG from cellular and molecular 
perspective of disease (5). These are just examples of 
an ongoing huge trend denoting a paradigm shift in 
medicine, which has started a couple of years ago (6).  
The above studies just as samples of many, 
indicate novel surveillance on the topics selected for 
continuing medical education and/or must be 
recommended to working anesthesiologists who may 
not be familiar to these everyday progressive concepts. 
Personalized medicine incorporates many aspects of 
patient care; all can be of interest for any hands-on 
anesthesiologist; though, drug administration seems to 
be one of the most comprehensible and applicable 
fields to start with leading to further steps, which open 
a many new horizons and impressive turning points to 
our conventional practice of medicine including 
anesthesiology and perioperative medicine. 
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